Results 61 to 70 of about 493,523 (218)
Mechanical circulatory support in cardiogenic shock
Journal of Intensive Care, 2023 Cardiogenic shock is a complex and diverse pathological condition characterized by reduced myocardial contractility. The goal of treatment of cardiogenic shock is to improve abnormal hemodynamics and maintain adequate tissue perfusion in organs.
Jun Nakata +5 more
doaj +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy +15 more
wiley +1 more source
Spontaneous Coronary Artery Dissection with Cardiogenic Shock in the United States
Reviews in Cardiovascular MedicineBackground: Spontaneous coronary artery dissection (SCAD) is defined as a non-traumatic separation of the epicardial coronary artery walls that creates a false lumen.
Chayakrit Krittanawong +8 more
doaj +1 more source
Stress induced cardiomyopathy complicated by cardiogenic shock: A non-survivor case
Egyptian Journal of Critical Care Medicine, 2018 Stress induced cardiomyopathy complicated by refractory cardiogenic shock is challenging as treatment by inotropes and vasopressors may be ineffective.
M. Abouelwafa +8 more
doaj +1 more source
Current concepts in the management of cardiogenic shock
, 2014 Richard G TrohmanCardiology, Electrophysiology, Arrhythmia and Pacemaker Service, Department of Medicine, Rush University Medical Center, Chicago, IL, USAAbstract: Cardiogenic shock most commonly results from myocardial infarction and is associated with ...
Trohman RG
core
Inotropic agents in cardiogenic shock
, 2020 PURPOSE OF REVIEW: Cardiogenic shock is a multifactorial and diverse entity in which inotropes are the cornerstone therapy. Although published clinical trials have focused on pharmacologic treatment of cardiogenic shock, there is lack of an established ...
Parissis, J. +3 more
core +1 more source
Percutaneous ventricular assist devices for cardiogenic shock
, 2008 Cardiogenic shock complicates up to 7% of ST-segment elevation myocardial infarctions and 2.5% of non-ST-segment elevation myocardial infarctions, with an associated mortality of 50% to 70%.
Windecker, Stephan, Cook, Stéphane
core
Post Myocardial Infarction Cardiogenic Shock
, 2011 Cardiogenic shock is often a devastating consequence of acute myocardial infarction (MI) and portends to significant mortality and morbidity. Despite improvements in expediting the time to treatment and enhancements in available medical therapy and ...
Yerem Yeghiazarians, Ramford Ng
core +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh +18 more
wiley +1 more source
Неотложная медицинская помощь, 2016 . The article addresses current approaches to the management of cardiogenic shock developed in patients with acute myocardial infarction. The authors present the data on the pathogenesis, clinical manifestations of this complication, and also a detailed ...
S. R. Giliarevsky +3 more
doaj